We are live on ! Find out more
HL

HeadInvest LLC Portfolio holdings

AUM $488M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+14.33%
3 Year Est. Return
+45.6%
5 Year Est. Return
+60.16%
10 Year Est. Return
+205.21%
AUM
$469M
AUM Growth
-$44.9M
Cap. Flow
-$73.9M
Cap. Flow %
-15.74%
Top 10 Hldgs %
29.41%
Holding
238
New
3
Increased
25
Reduced
145
Closed
32

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$11.2M
2
MSFT icon
Microsoft
MSFT
+$3.49M
3
XOM icon
ExxonMobil
XOM
+$2.49M
4
WMT icon
Walmart Inc
WMT
+$2.09M
5
AAPL icon
Apple
AAPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Healthcare 9.06%
3 Financials 5.94%
4 Consumer Staples 5.72%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRWD icon
151
CrowdStrike
CRWD
$183B
$427K 0.09%
3,352
-8
-0.2% -$867
PFE icon
152
Pfizer
PFE
$143B
$426K 0.09%
17,589
-4,366
-20% -$102K
XJR icon
153
iShares ESG Screened S&P Small-Cap ETF
XJR
$184M
$417K 0.09%
10,550
-1,460
-12% -$54.5K
ASML icon
154
ASML
ASML
$596B
$415K 0.09%
518
+18
+4% +$12.9K
ZTS icon
155
Zoetis
ZTS
$32.7B
$414K 0.09%
2,654
-224
-8% -$35.5K
SDY icon
156
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$413K 0.09%
3,043
IWF icon
157
iShares Russell 1000 Growth ETF
IWF
$117B
$413K 0.09%
3,888
-84
-2% -$8.03K
IUSG icon
158
iShares Core S&P US Growth ETF
IUSG
$30.4B
$408K 0.09%
2,710
-240
-8% -$32.5K
XBI icon
159
State Street SPDR S&P Biotech ETF
XBI
$10B
$402K 0.09%
4,846
-36
-0.7% -$2.87K
SNPS icon
160
Synopsys
SNPS
$71.6B
$396K 0.08%
773
-27
-3% -$12.6K
CHKP icon
161
Check Point Software Technologies
CHKP
$14.3B
$394K 0.08%
1,780
-51
-3% -$11.2K
TMFC icon
162
Motley Fool 100 Index ETF
TMFC
$1.99B
$373K 0.08%
5,783
QCOM icon
163
Qualcomm
QCOM
$164B
$369K 0.08%
2,320
-4,432
-66% -$652K
APD icon
164
Air Products & Chemicals
APD
$65.5B
$368K 0.08%
1,303
YUM icon
165
Yum! Brands
YUM
$41.9B
$366K 0.08%
2,471
-15
-0.6% -$2.19K
D icon
166
Dominion Energy
D
$62.1B
$366K 0.08%
6,477
-1,670
-20% -$91.5K
PWR icon
167
Quanta Services
PWR
$84.2B
$357K 0.08%
944
-60
-6% -$19.3K
CCI icon
168
Crown Castle
CCI
$34.6B
$355K 0.08%
3,459
-75
-2% -$7.59K
VEU icon
169
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$351K 0.07%
5,220
+500
+11% +$31.7K
TIP icon
170
iShares TIPS Bond ETF
TIP
$14.5B
$344K 0.07%
3,127
-872
-22% -$95.1K
CEG icon
171
Constellation Energy
CEG
$92.1B
$326K 0.07%
1,011
+3
+0.3% +$794
GPC icon
172
Genuine Parts
GPC
$17.9B
$325K 0.07%
2,678
-147
-5% -$17.7K
NKE icon
173
Nike
NKE
$64.1B
$317K 0.07%
4,456
-3,219
-42% -$193K
BND icon
174
Vanguard Total Bond Market
BND
$158B
$316K 0.07%
4,288
-300
-7% -$21.8K
UNP icon
175
Union Pacific
UNP
$174B
$315K 0.07%
1,369
-40
-3% -$8.88K

Similar funds

HeadInvest LLC's Q2 2025 Portfolio in Review

As of Q2 2025, HeadInvest LLC held 238 positions worth $469M, down 8.7% from $514M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HeadInvest LLC withdrew a net $73.9M in Q2 2025, closing 32 positions and reducing 145 holdings. Its most notable exit was Roper Technologies, an estimated $1.13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, HeadInvest LLC opened a new position in Ralliant Corp worth $571K.

  • HeadInvest LLC's largest Q2 2025 buy was Ralliant Corp: 10,785 shares worth $571K.
  • HeadInvest LLC added most to Vanguard FTSE Developed Markets ETF in Q2 2025, an estimated $1.17M increase.
  • HeadInvest LLC's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $11.2M.
  • HeadInvest LLC fully exited Roper Technologies in Q2 2025, selling an estimated $1.13M.
  • HeadInvest LLC's ten largest holdings make up 29% of its $469M portfolio in Q2 2025.
  • HeadInvest LLC opened 3 new positions and closed 32 in Q2 2025.
  • HeadInvest LLC's portfolio value fell 8.7% quarter-over-quarter to $469M.

Based on HeadInvest LLC's 13F filing for Q2 2025, filed 14 Aug 2025.